164 results
Page 8 of 9
6-K
EX-99.1
vxvjz1d3
26 Aug 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.1
x9nhu63fqhudh
26 Aug 14
RepliCel Announces 2014 Second Quarter Financial Results
12:00am
6-K
EX-99.1
yycfeawx7 v0n
17 Jul 14
RepliCel Appoints Brooke Hurford as Corporate Secretary and Director, Finance
12:00am
6-K
EX-99.1
yu5xejsvtow1s3sgwf
23 Jun 14
RepliCel Retains O&M Partners to Coordinate North American Focused Investor Marketing Campaign
12:00am
6-K
EX-99.1
2tiooxryj8jtxgyfz 2j
18 Jun 14
RepliCel Life Sciences Announces Closing of Third and Final Tranche of
12:00am
6-K
EX-99.1
8w3y6za9o y5s
6 Jun 14
Replicel Life Sciences Inc. 6-K
12:00am
6-K
EX-99.2
q6qpmrirattu6t7 5tw
29 May 14
Current report (foreign)
12:00am
6-K
EX-99.1
5gewzc
29 May 14
Current report (foreign)
12:00am
6-K
EX-99.1
o1w5z 4l0a6
22 May 14
Current report (foreign)
12:00am
6-K
EX-99.1
e1jaqezpib7 kuoskej2
22 May 14
Replicel Life Sciences Inc. Form 6-K
12:00am
6-K
EX-99.1
6ib2qcx17anjj
18 Mar 14
Current report (foreign)
12:00am
6-K
EX-99.2
0aoybw
18 Mar 14
Current report (foreign)
12:00am
6-K
EX-99.1
s7k6je snj2ppk8dglv
27 Feb 14
Replicel Life Sciences Inc. Form 6-K
12:00am
6-K
EX-99.1
dufy4br4c
27 Feb 14
RepliCel to Present RCH-01 Phase 1 Clinical Data at the 13th Congress
12:00am
6-K
EX-99
j50 bqab1
9 Jan 14
RepliCel to Commence Trading on the TSX Venture Exchange
12:00am
6-K
m6g1d wr084n
20 Nov 13
Current report (foreign)
12:00am
6-K
EX-99.1
povtwzazb9s7z mt9eg9
28 Aug 13
Current report (foreign)
12:00am
6-K
EX-99.1
nps2ehm5fj781k
12 Jul 13
Current report (foreign)
12:00am
6-K
EX-99.2
p4yms6wlv24is 7gk
12 Jul 13
Current report (foreign)
12:00am